Boundless Bio, Inc. Common Stock / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €273.58K
    Gross profit
    -€273.58K
    SG&A expenses
    €16.95M
    R&D expenses
    €44.40M
    EBITDA
    -€59.67M
    D&A
    €755.16K
    EBIT
    -€61.62M
    Interest expenses
    €0.00
    EBT
    -€55.57M
    Tax expenses
    €0.00
    Net income
    -€55.57M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €743.07K
    Changes in working capital
    €424.61K
    Operating cash flow
    -€47.63M
    Capex
    €911.37K
    Other investing cash flow
    €0.00
    Net investing cash flow
    €33.06M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €187.28K
    Net financing cash flow
    €187.28K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€14.38M
    Cash at end of period
    €13.17M
    Free cash flow
    -€46.72M

    Balance sheet

    Cash and cash equivalents
    €12.68M
    Cash and short-term investments
    €109.73M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €2.19M
    Total current assets
    €111.93M
    Property, plant & equipment
    €42.43M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €483.30K
    Other non-current assets
    €37.97K
    Total non-current assets
    €42.95M
    Total assets
    €154.87M
    Accounts payable
    €1.98M
    Short-term debt
    €1.69M
    Other current liabilities
    €4.28M
    Total current liabilities
    €7.95M
    Long-term debt
    €82.07M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €41.04M
    Total liabilities
    €48.99M
    Common stock
    €1.73K
    Retained earnings
    -€201.01M
    Other equity
    -€3.45K
    Total equity
    €105.89M
    Total liabilities and shareholders' equity
    €154.87M

    Company information

    Market capitalization
    €93.91M
    Employees
    72
    Enterprise Value
    €57.19M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -52.5%
    ROA
    -35.9%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -51.7%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€771.82K

    Notifications